Riverdale actor Lili Reinhart sat down with Inc. at SXSW to discuss her new entrepreneurial venture, Personal Day.
TVB-3567 is the Company’s second fatty acid synthase (FASN) inhibitor First-in-human Phase 1 trial initiation planned in 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results